After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

Illumina is the world's largest provider ... system offers the potential to undertake multiomics by enabling RNA and protein sequencing on Illumina platforms which is not possible with ctDNA.

With an installed base of more than 25,000 sequencing systems, Illumina holds around 80% of ... Avidity Biosciences (RNA-1.75%) develops targeted RNA therapeutics. It specializes in antibody ...